Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

BioCorRx (BICX) Non-Current Deferred Tax Liability (2016 - 2024)

BioCorRx (BICX) has disclosed Non-Current Deferred Tax Liability for 9 consecutive years, with $39349.0 as the latest value for Q4 2024.

  • Quarterly Non-Current Deferred Tax Liability fell 80.32% to $39349.0 in Q4 2024 from the year-ago period, while the trailing twelve-month figure was $39349.0 through Dec 2024, down 80.32% year-over-year, with the annual reading at $39349.0 for FY2024, 80.32% down from the prior year.
  • Non-Current Deferred Tax Liability hit $39349.0 in Q4 2024 for BioCorRx, down from $199952.0 in the prior quarter.
  • In the past five years, Non-Current Deferred Tax Liability ranged from a high of $361781.0 in Q4 2022 to a low of $39349.0 in Q4 2024.
  • Historically, Non-Current Deferred Tax Liability has averaged $200360.7 across 3 years, with a median of $199952.0 in 2023.
  • Biggest five-year swings in Non-Current Deferred Tax Liability: crashed 44.73% in 2023 and later plummeted 80.32% in 2024.
  • Year by year, Non-Current Deferred Tax Liability stood at $361781.0 in 2022, then tumbled by 44.73% to $199952.0 in 2023, then tumbled by 80.32% to $39349.0 in 2024.
  • Business Quant data shows Non-Current Deferred Tax Liability for BICX at $39349.0 in Q4 2024, $199952.0 in Q4 2023, and $361781.0 in Q4 2022.